misleading statements

Vistagen investors face March 16, 2026 deadline in securities lawsuit alleging false statements about drug trials and clinical data that misled shareholders.

Class action lawsuit filed against REGENXBIO for allegedly making false statements about gene therapy safety and efficacy while withholding adverse trial information from investors.

PayPal faces class action lawsuit alleging false statements about Branded Checkout growth prospects. Investors who purchased securities Feb 2025-Feb 2026 invited to join litigation.

Mereo BioPharma faces class action lawsuit over allegedly false statements regarding failed Phase 3 clinical trials. Investors who bought securities between June 2023-December 2025 may be eligible to participate.

uniQure faces securities class action lawsuit over allegedly false FDA approval statements. Investors who purchased stock between September-October 2025 can join the case by April 2026.

Rosen Law Firm sues PomDoctor Ltd. for stock promotion fraud and misleading statements. Investors must act by April 7, 2026 deadline to join the class action.

Law firm investigates Gemini Space Station for alleged securities violations after three senior executives departed unexpectedly, causing stock to drop 12.9%.

PayPal faces class action lawsuit for allegedly making false statements about 2027 financial targets and Branded Checkout capabilities. Affected investors urged to seek legal counsel promptly.

Mereo BioPharma faces securities litigation alleging it misled investors about Phase 3 clinical trial results for setrusumab, failing to disclose the trials missed primary endpoints.

Klarna faces securities class action over allegedly misleading IPO statements about loss reserves. Lead plaintiff deadline set for February 20, 2026.

Law firm sues China Liberal Education Holdings for securities fraud, alleging misleading statements about share manipulation in January 2025. Seeking lead plaintiffs from affected investors.

Picard Medical faces securities fraud class action over misleading statements and stock promotion in 2025. Investors must file claims by April 3, 2026.

Levi & Korsinsky launches class action against Paysafe for securities fraud. Shareholders must file lead plaintiff requests by April 7, 2026.

BellRing Brands faces securities lawsuit alleging false sales disclosures. Stock fell 51.6% after company allegedly misattributed inventory hoarding to market demand.

BellRing Brands faces securities fraud lawsuit alleging it misrepresented sales growth, claiming inventory stockpiling rather than organic demand drove performance, inflating stock valuations.

Class action lawsuit filed against Inovio Pharmaceuticals for allegedly making false statements about device manufacturing capabilities and regulatory timelines between October 2023 and December 2025.

uniQure faces class action lawsuit alleging misleading FDA approval statements and understated BLA timeline risks. Investors who purchased securities between September-October 2025 may be eligible to participate.

REGENXBIO faces securities class action alleging false statements about RGX-111 gene therapy program and clinical trial outcomes. Investors from February 2022-January 2026 may recover damages.

Portnoy Law Firm filed securities class action against Ultragenyx Pharmaceutical, alleging the company made false statements about investigational drug setrusumab and concealed material clinical trial risks.

Varonis Systems faces class action lawsuit after stock plunged 48.67% on October 29 following missed revenue projections and weak customer conversions disclosure.